MEDISTIM ASA: årsregnskap 2021 vs 2020
Shrank 100% on revenue, stronger earnings
approved 2022-04-27; registry 2022-08-18; journal 2022 883285
Summary
What changed
Comparing Årsregnskap 2021 with 2020 for MEDISTIM ASA. Revenue 195.44m NOK → 258.5k NOK (-99.9%). Net result +60.17m NOK → +80.68m NOK. Equity 140.5k NOK → 160.3k NOK.
On the constructive side: operating result improved; net result improved; equity strengthened. Pressures included: revenue fell; cogs moved.
Also worth watching: paid-in equity reduced; book investments changed. All figures are taken from the published annual accounts for MEDISTIM ASA.
At a glance
Scorecard
What improved
-
↑
Operating result improved
Operating result +45.41m NOK → +77.28m NOK (op. margin 23.2% → 29893.5%). Calculated
-
↑
Net result improved
Net result +60.17m NOK → +80.68m NOK (net margin 30.8% → 31209.0%). Calculated
-
↑
Equity strengthened
Book equity 140.5k NOK → 160.3k NOK (equity ratio 57.6% → 51.7%). Calculated
-
↑
Cash rose
Bank deposits 19.95m NOK → 75.15m NOK (+276.6% YoY). Calculated
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 195.44m NOK to 258.5k NOK (-99.9% YoY). Calculated
-
↓
COGS moved
COGS / varekostnad 37.66m NOK → 54.58m NOK (+44.9% YoY). Calculated
Things to notice
-
·
Paid-in equity reduced
Paid-in equity fell 4.58m NOK → 160.3k NOK — check capital reduction, conversion, or reclassification. Interpretation
-
·
Book investments changed
Investment / intangible book value 45.95m NOK → 48.38m NOK. Reported fact